Celcuity (CELC) Accumulated Expenses (2016 - 2025)
Celcuity (CELC) posted Accumulated Expenses of $27.3 million for Q3 2025, down 4.77% on a QoQ basis from $28.6 million in Q2 2025, and up 60.7% year-over-year from $17.0 million in Q3 2024.
Celcuity (CELC) Accumulated Expenses (2016 - 2025) Analysis & Trends
Celcuity's Accumulated Expenses history runs 10 years deep, the most recent figure standing at $27.3 million for Q3 2025.
- Quarterly Accumulated Expenses rose 60.7% year-over-year to $27.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $27.3 million (up 60.7% YoY) and the FY2024 annual result came in at $22.2 million, up 38486.64% from the prior year.
- Accumulated Expenses was $27.3 million for Q3 2025 at Celcuity, down from $28.6 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $28.6 million in Q2 2025 and bottomed at $57494.0 in Q4 2023.
- A 5-year average of $8.7 million and a median of $3.3 million in 2022 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Accumulated Expenses sank 93.81% — and 2024, when it soared 38486.64%.
- Celcuity's Accumulated Expenses stood at $438477.0 in 2021, then jumped by 111.92% to $929216.0 in 2022, then sank by 93.81% to $57494.0 in 2023, then surged by 38486.64% to $22.2 million in 2024, then advanced by 22.96% to $27.3 million in 2025.
- Business Quant data shows CELC's Accumulated Expenses at $27.3 million in Q3 2025, $28.6 million in Q2 2025, and $22.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27.28 Mn |
| Jun 30, 2025 | 28.64 Mn |
| Mar 31, 2025 | 22.82 Mn |
| Dec 31, 2024 | 22.19 Mn |
| Sep 30, 2024 | 16.97 Mn |
| Jun 30, 2024 | 13.15 Mn |
| Mar 31, 2024 | 11.24 Mn |
| Dec 31, 2023 | 57,494.00 |
| Sep 30, 2023 | 6.89 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 3.04 Mn |
| Dec 31, 2022 | 929,216.00 |
| Sep 30, 2022 | 3.28 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 438,477.00 |
| Sep 30, 2021 | 879,851.00 |
| Jun 30, 2021 | 729,672.00 |
| Mar 31, 2021 | 660,849.00 |
| Dec 31, 2020 | 137,020.00 |